Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)

Expanded access is temporarily not available for this treatment.
Sponsor:
Information provided by:
Children's Hospital Los Angeles
ClinicalTrials.gov Identifier:
NCT00870636
First received: March 26, 2009
Last updated: March 27, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is temporarily not available for this treatment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given